RhythmAnalytics vs EchoGo® Heart Failure
Similar category, different focus. These tools serve overlapping but distinct needs.
Comparability 65/100
Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
AI Verdict
RhythmAnalytics specializes in the AI-powered interpretation of single-lead ECG data to detect various cardiac arrhythmias, offering clinical decision support for rhythm disorders. EchoGo® Heart Failure, conversely, utilizes AI to analyze routine echocardiograms for the detection of Heart Failure with preserved Ejection Fraction (HFpEF). While both are FDA-cleared AI tools providing clinical decision support in cardiology, they operate on different diagnostic modalities (ECG vs. echocardiogram) and target distinct cardiac conditions.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Frequently Asked Questions
RhythmAnalytics by Biofourmis focuses on the automated interpretation and detection of over 15 types of cardiac arrhythmias, including AFib, ventricular arrhythmias, and ectopic beats, from single-lead ECG data. EchoGou00ae Heart Failure by Ultromics specifically analyzes routine echocardiograms to detect Heart Failure with preserved Ejection Fraction (HFpEF).
RhythmAnalytics requires single-lead ECG data and is compatible with FDA-cleared ECG devices such as Holter monitors, event recorders, and wearable sensors. EchoGou00ae Heart Failure utilizes routine echo video clips for its analysis to detect HFpEF.
RhythmAnalytics is a cloud-based API, allowing for integration into existing cardiac monitoring solutions or directly into medical devices or wearable sensors. EchoGou00ae Heart Failure offers seamless integration with existing workflows and IT stacks, utilizing a DICOM workflow for report delivery directly to PACS.
RhythmAnalytics provides AI-based automated interpretation of cardiac arrhythmias, including beat-by-beat morphology computation, QRS and Ventricular Ectopic Beat detection, and rhythm analysis for clinical decision support. EchoGou00ae Heart Failure delivers AI-powered HFpEF detection insights within 20 minutes of analysis, presented as automated structured reports.
For RhythmAnalytics, pricing information is not specified and requires contacting the vendor, so no reimbursement details are provided. EchoGou00ae Heart Failure is reimbursable via CPT code 0932T for outpatient analysis, with a national Medicare average of $316 per analysis, and is covered by Medicare and select commercial insurers.
RhythmAnalytics demonstrated cardiologist-level arrhythmia detection with 90.8% sensitivity, 98.2% specificity, and an F1 score of 0.834, outperforming other deep learning systems and a panel of cardiologists. EchoGou00ae Heart Failure is clinically validated with 90% sensitivity and 86% specificity for HFpEF detection, trained on over 10 years of outcome data.